Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IST:ANGEN's OCF Margin % is ranked better than 98.4% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.82
vs IST:ANGEN: 42.00
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve OCF Margin % Related Terms
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve OCF Margin % Chart
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve OCF Margin % vs Medical Devices & Instruments Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) has a OCF Margin % of 34.68% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve and its competitors. This is 23% below median its historical median of 44.83. Over the past decade, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's OCF Margin % has ranged from 20.32 to 127.34. According to the industry distribution chart, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve ranks #13 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 1.6%.
Is Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's OCF Margin % too high?
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's current OCF Margin % of 34.68% is 23% below median its 10-year median of 44.83. Over the past 10 years, this metric has ranged from a low of 20.32 to a high of 127.34. The Medical Devices & Instruments industry median OCF Margin % is 5.82. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's value of 34.68% is 495.9% above this industry median. Based on the distribution chart, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve ranks #13 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve ranks #13 out of 815 companies for OCF Margin %. This places Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve in the top 2% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.82. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's value of 34.68% is 495.9% above this benchmark. Historically, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's own OCF Margin % has ranged from 20.32 to 127.34 over the past decade. While the company's 10-year median is 44.83 vs. the industry median of 5.82, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.82, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's current OCF Margin % of 34.68% is 495.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's current OCF Margin % is 34.68%, which is 23% below median its own 10-year median of 44.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve stock overvalued right now?
Based on GuruFocus' analysis, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) is currently considered Possible Value Trap. The stock's GF Value™ is ₺18.66, compared to a current price of ₺10.19 — trading 45.4% below its estimated fair value. The current OCF Margin % is 34.68%, which is 23% below median its 10-year median of 44.83 and 495.9% above the Medical Devices & Instruments industry median of 5.82. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN), the current OCF Margin % is 34.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) Overvalued in 2026?
Based on GuruFocus' analysis, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve stock appears to be undervalued.
The current stock price of ₺10.19 is trading 45.4% below its estimated GF Value™ of ₺18.66.
GuruFocus considers Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve to be Possible Value Trap.
Key valuation signals for IST:ANGEN:
OCF Margin %: 34.68% (23% below median its 10-year median of 44.83)
GF Value™: ₺18.66 vs. price of ₺10.19 (45.4% below fair value)
Industry Position: 495.9% above the Medical Devices & Instruments median (#13 of 815)
No single metric tells the full story. See the IST:ANGEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Business Description
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi Ve Ticaret AS is an international biotechnology company. It is engaged in designing, developing, and manufacturing Real-Time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments. It also manufactures NA Extraction kits, Microbiology kits, Genetic Disorders kits, Panel kits, Sequencing kits, Food Testing kits.
58GF Score
Get the complete analysis for IST:ANGEN
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:ANGEN has been successfully added to your 
